ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia (i) Plozasiran ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia (ii) Olezarsen KEYNOTE: Genetics of familial chylomicronaemia syndrome (FCS) and severe hypertriglyceridaemia See more 6th Closed Scientific Expert Meeting of the Editorial Board Amsterdam, The Netherlands, 24th August, 2023 (Educational supporters) CVD and omega-3 fatty acids: Is arterial inflammation the key? CVD risk reduction in HIV infection: The REPRIEVE Trial Insights into apoC3’s mechanism of action See more 5th Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 19th April, 2023 (Educational supporters) ANGPTL8: The third musketeer? Fibrates: Finished or still fighting? Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1 See more 4th Closed Scientific Expert Meeting of the Editorial Board Barcelona, Spain, 26th August, 2022 (Educational supporters) ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ApoC3 as a therapeutic target for treatment of severe hypertriglyceridaemia (ii) Olezarsen KEYNOTE: Genetics of familial chylomicronaemia syndrome (FCS) and severe hypertriglyceridaemia See more 6th Closed Scientific Expert Meeting of the Editorial Board Amsterdam, The Netherlands, 24th August, 2023 (Educational supporters) CVD and omega-3 fatty acids: Is arterial inflammation the key? CVD risk reduction in HIV infection: The REPRIEVE Trial Insights into apoC3’s mechanism of action See more 5th Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 19th April, 2023 (Educational supporters) ANGPTL8: The third musketeer? Fibrates: Finished or still fighting? Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1 See more 4th Closed Scientific Expert Meeting of the Editorial Board Barcelona, Spain, 26th August, 2022 (Educational supporters) ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
KEYNOTE: Genetics of familial chylomicronaemia syndrome (FCS) and severe hypertriglyceridaemia See more
CVD and omega-3 fatty acids: Is arterial inflammation the key? CVD risk reduction in HIV infection: The REPRIEVE Trial Insights into apoC3’s mechanism of action See more 5th Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 19th April, 2023 (Educational supporters) ANGPTL8: The third musketeer? Fibrates: Finished or still fighting? Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1 See more 4th Closed Scientific Expert Meeting of the Editorial Board Barcelona, Spain, 26th August, 2022 (Educational supporters) ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
CVD risk reduction in HIV infection: The REPRIEVE Trial Insights into apoC3’s mechanism of action See more 5th Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 19th April, 2023 (Educational supporters) ANGPTL8: The third musketeer? Fibrates: Finished or still fighting? Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1 See more 4th Closed Scientific Expert Meeting of the Editorial Board Barcelona, Spain, 26th August, 2022 (Educational supporters) ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ANGPTL8: The third musketeer? Fibrates: Finished or still fighting? Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1 See more 4th Closed Scientific Expert Meeting of the Editorial Board Barcelona, Spain, 26th August, 2022 (Educational supporters) ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Fibrates: Finished or still fighting? Tm6sf2 in VLDL metabolism: More complicated than we thought – Part 1 See more 4th Closed Scientific Expert Meeting of the Editorial Board Barcelona, Spain, 26th August, 2022 (Educational supporters) ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ANGPTL3, 4 and 8: Emerging relevance to cardiometabolic disease ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ANGPTL3/8 inhibition: Clinical results ApoCIII inhibition: Impact of TG lowering See more 3rd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 13th April, 2022 (Educational supporters) ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
ApoCIII and ANGPTL3 inhibition: A breakthrough in lowering triglyceride-rich lipoproteins? Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – What have we learned from triglyceride lowering trials using fibrates over the past 40 years? Novel PPAR agonists as therapeutics in hypertriglyceridaemia See more 2nd Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 18th October, 2021 (Educational supporters) Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – Lipid assessment and treatment of patients post-pancreatitis: Diet and lifestyle Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – Medical treatment options for hypertriglyceridaemia after pancreatitis Keynote – Pancreatitis: Genetic complexity See more 1st Closed Scientific Expert Meeting of the Editorial Board Virtual meeting, 20th May, 2021 (Educational supporters) Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more Educational partners and supporters Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Keynote – Role of triglyceride-rich lipoproteins in residual cardiovascular risk Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more
Keynote – Atherogenic potential of postprandial lipaemia in diabetes Keynote – Relevance of TRL and remnants in FH See more